2022 West Oncology Conference | Lung Cancers | Q&A and Panel Discussion

preview_player
Показать описание
Welcome to a Q&A and case panel discussion where our experts will cover implications from new data that will change practice in lung cancer treatment, while answering audience questions. Expert panelists include Dr. Shayma Kazmi from Penn Medicine, Dr. Ramakrishna Battini, Dr. Jason Porter, and Dr. Holger Gieschen from West Cancer Center.

To obtain credit for this CME activity you must watch the full 2022 West Oncology Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.
Рекомендации по теме
Комментарии
Автор

1) Osimertinib needed
2) Atezolizumab after progression
3) chemotherapy (platinum dublet 3 courses after radiation therapy, then Durvalumab
4) SBRT!!!!
5) Pembrolizumab

zamirabdullin